{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:01:46Z","timestamp":1791270106839,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral squamous cell carcinomas are one of the most common cancers worldwide with aggressive behavior and poor prognosis. Reactive oxygen species (ROS) are associated with cancer and cause various types of regulated cell death (RCD). Inducing the RCD pathway by modulating ROS levels is imperative to conquer cancers. The aim of this study is to investigate the synergistic anticancer effects of melatonin and erastin on ROS modulation and subsequent RCD induction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Human tongue squamous cell carcinoma cell lines (SCC-15 cells) were treated with melatonin, erastin, or their combination. Cell viability, ROS levels, autophagy, apoptosis, and ferroptosis levels were tested according to the results of the PCR array, which were verified with\/without the induction and inhibition of ROS by H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub> and N-acetyl-L-cysteine, respectively. In addition, a mouse-based subcutaneous oral cancer xenograft model was constructed to identify the effects of melatonin, erastin, and their combination on the autophagy, apoptosis, and ferroptosis levels in isolated tumor tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>ROS levels were increased by the administration of melatonin at high concentrations (mM), and the combination of melatonin with erastin enhanced the levels of malonic dialdehyde, ROS, and lipid ROS, and reduced the levels of glutamate and glutathione. SQSTM1\/p62, LC3A\/B, cleaved caspase-3, and PARP1 protein levels in SCC-15 cells were also increased by melatonin\u2009plus\u2009erastin treatment, which further increased as ROS accumulated, and decreased as ROS levels were suppressed. Combined treatment of melatonin and erastin markedly reduced the tumor size in\u00a0vivo, demonstrated no obvious systemic side effects, and significantly enhanced the apoptosis and ferroptosis levels in the tumor tissues, in parallel with decreased autophagy levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Melatonin combined with erastin exhibits synergistic anticancer effects without adverse reactions. Herein, this combination might become a promising alternative strategy for oral cancer treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s11658-023-00449-6","type":"journal-article","created":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T17:03:05Z","timestamp":1683046985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Melatonin and erastin emerge synergistic anti-tumor effects on oral squamous cell carcinoma by inducing apoptosis, ferroptosis, and inhibiting autophagy through promoting ROS"],"prefix":"10.1186","volume":"28","author":[{"given":"Leilei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoying","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangyong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-4277","authenticated-orcid":false,"given":"Wing Shan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"449_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pi\u00f1eros M, et\u00a0al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144:1941\u201353.","journal-title":"Int J Cancer"},{"key":"449_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.oraloncology.2017.11.015","volume":"76","author":"L Jansen","year":"2018","unstructured":"Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, et\u00a0al. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol. 2018;76:8\u201315.","journal-title":"Oral Oncol"},{"key":"449_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.105","volume":"7","author":"E Panieri","year":"2016","unstructured":"Panieri E, Santoro MM. ROS homeostasis and metabolism: a dangerous liason in cancer cells. Cell Death Dis. 2016;7: e2253.","journal-title":"Cell Death Dis"},{"key":"449_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.semcancer.2013.12.007","volume":"25","author":"A Costa","year":"2014","unstructured":"Costa A, Scholer-Dahirel A, Mechta-Grigoriou F. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Semin Cancer Biol. 2014;25:23\u201332.","journal-title":"Semin Cancer Biol"},{"key":"449_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12:931\u201347.","journal-title":"Nat Rev Drug Discov"},{"key":"449_CR6","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","volume":"48","author":"ML Circu","year":"2010","unstructured":"Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med. 2010;48:749\u201362.","journal-title":"Free Radic Biol Med"},{"key":"449_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","volume":"45","author":"L Ouyang","year":"2012","unstructured":"Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et\u00a0al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487\u201398.","journal-title":"Cell Prolif"},{"key":"449_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et\u00a0al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25:486\u2013541.","journal-title":"Cell Death Differ"},{"key":"449_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","volume":"108","author":"RW Johnstone","year":"2002","unstructured":"Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153\u201364.","journal-title":"Cell"},{"key":"449_CR10","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/hed.24803","volume":"39","author":"CC Hung","year":"2017","unstructured":"Hung CC, Chien CY, Chu PY, Wu YJ, Lin CS, Huang CJ, et\u00a0al. Differential resistance to platinum-based drugs and 5-fluorouracil in p22phox-overexpressing oral squamous cell carcinoma: Implications of alternative treatment strategies. Head Neck. 2017;39:1621\u201330.","journal-title":"Head Neck"},{"key":"449_CR11","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et\u00a0al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"449_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et\u00a0al. Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell. 2017;171:273\u201385.","journal-title":"Cell"},{"key":"449_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59:298\u2013308.","journal-title":"Mol Cell"},{"key":"449_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1078-0432.CCR-12-2621","volume":"19","author":"H Yamaguchi","year":"2013","unstructured":"Yamaguchi H, Hsu JL, Chen CT, Wang YN, Hsu MC, Chang SS, et\u00a0al. Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. Clin Cancer Res. 2013;19:845\u201354.","journal-title":"Clin Cancer Res"},{"key":"449_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2016.07.035","volume":"381","author":"JL Roh","year":"2016","unstructured":"Roh JL, Kim EH, Jang HJ, Park JY, Shin D. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer. Cancer Lett. 2016;381:96\u2013103.","journal-title":"Cancer Lett"},{"key":"449_CR16","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.3892\/or.2015.3712","volume":"33","author":"L Chen","year":"2015","unstructured":"Chen L, Li X, Liu L, Yu B, Xue Y, Liu Y. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-gamma-lyase function. Oncol Rep. 2015;33:1465\u201374.","journal-title":"Oncol Rep"},{"key":"449_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396.","journal-title":"Cancer Cell"},{"key":"449_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02523","volume":"3","author":"SJ Dixon","year":"2014","unstructured":"Dixon SJ, Patel DN, Welsch M, Skouta R, Lee ED, Hayano M, et\u00a0al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis. Elife. 2014;3: e02523.","journal-title":"Elife"},{"key":"449_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jid.2017.10.025","volume":"138","author":"AT Slominski","year":"2018","unstructured":"Slominski AT, Hardeland R, Zmijewski MA, Slominski RM, Reiter RJ, Paus R. Melatonin: a cutaneous perspective on its production, metabolism, and functions. J Invest Dermatol. 2018;138:490\u20139.","journal-title":"J Invest Dermatol"},{"key":"449_CR20","doi-asserted-by":"publisher","first-page":"39896","DOI":"10.18632\/oncotarget.16379","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu DP, et\u00a0al. Melatonin for the prevention and treatment of cancer. Oncotarget. 2017;8:39896\u2013921.","journal-title":"Oncotarget"},{"key":"449_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12935-021-01892-1","volume":"21","author":"S Mehrzadi","year":"2021","unstructured":"Mehrzadi S, Pourhanifeh MH, Mirzaei A, Moradian F, Hosseinzadeh A. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress. Cancer Cell Int. 2021;21:188.","journal-title":"Cancer Cell Int"},{"key":"449_CR22","first-page":"8223737","volume":"2022","author":"M Li","year":"2022","unstructured":"Li M, Yang N, Hao L, Zhou W, Li L, Liu L, et\u00a0al. Melatonin inhibits the ferroptosis pathway in rat bone marrow mesenchymal stem cells by activating the PI3K\/AKT\/mTOR signaling axis to attenuate steroid-induced osteoporosis. Oxid Med Cell Longev. 2022;2022:8223737.","journal-title":"Oxid Med Cell Longev"},{"key":"449_CR23","doi-asserted-by":"publisher","first-page":"4776243","DOI":"10.1155\/2022\/4776243","volume":"2022","author":"YB Huang","year":"2022","unstructured":"Huang YB, Jiang L, Liu XQ, Wang X, Gao L, Zeng HX, et\u00a0al. Melatonin alleviates acute kidney injury by inhibiting NRF2\/Slc7a11 axis-mediated ferroptosis. Oxid Med Cell Longev. 2022;2022:4776243.","journal-title":"Oxid Med Cell Longev"},{"key":"449_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nm.4232","volume":"23","author":"SL Cramer","year":"2017","unstructured":"Cramer SL, Saha A, Liu J, Tadi S, Tiziani S, Yan W, et\u00a0al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat Med. 2017;23:120\u20137.","journal-title":"Nat Med"},{"key":"449_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/jpi.12267","volume":"59","author":"LC Manchester","year":"2015","unstructured":"Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, et\u00a0al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403\u201319.","journal-title":"J Pineal Res"},{"key":"449_CR26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.lfs.2004.03.003","volume":"75","author":"J Leon","year":"2004","unstructured":"Leon J, Acu\u00f1a-Castroviejo D, Sainz RM, Mayo JC, Tan DX, Reiter RJ. Melatonin and mitochondrial function. Life Sci. 2004;75:765\u201390.","journal-title":"Life Sci"},{"key":"449_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13105-019-00671-x","volume":"75","author":"M Estaras","year":"2019","unstructured":"Estaras M, Moreno N, Santofimia-Casta\u00f1o P, Martinez-Morcillo S, Roncero V, Blanco G, et\u00a0al. Melatonin induces reactive oxygen species generation and changes in glutathione levels and reduces viability in human pancreatic stellate cells. J Physiol Biochem. 2019;75:185\u201397.","journal-title":"J Physiol Biochem"},{"key":"449_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1600-079X.2008.00585.x","volume":"45","author":"RM Sainz","year":"2008","unstructured":"Sainz RM, Reiter RJ, Tan DX, Roldan F, Natarajan M, Quiros I, et\u00a0al. Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J Pineal Res. 2008;45:258\u201370.","journal-title":"J Pineal Res"},{"key":"449_CR29","doi-asserted-by":"publisher","first-page":"e12461","DOI":"10.1111\/jpi.12461","volume":"64","author":"YQ Shen","year":"2018","unstructured":"Shen YQ, Guerra-Librero A, Fernandez-Gil BI, Florido J, Garc\u00eda-L\u00f3pez S, Martinez-Ruiz L, et\u00a0al. Combination of melatonin and rapamycin for head and neck cancer therapy: Suppression of AKT\/mTOR pathway activation, and activation of mitophagy and apoptosis via mitochondrial function regulation. J Pineal Res. 2018;64:e12461.","journal-title":"J Pineal Res"},{"key":"449_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jpi.12162","volume":"57","author":"HM Zhang","year":"2014","unstructured":"Zhang HM, Zhang Y. Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res. 2014;57:131\u201346.","journal-title":"J Pineal Res"},{"key":"449_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: The first metal based anticancer drug. Bioorg Chem. 2019;88: 102925.","journal-title":"Bioorg Chem"},{"key":"449_CR32","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1517\/14728222.2013.834890","volume":"17","author":"M Bizzarri","year":"2013","unstructured":"Bizzarri M, Proietti S, Cucina A, Reiter RJ. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin Ther Targets. 2013;17:1483\u201396.","journal-title":"Expert Opin Ther Targets"},{"key":"449_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/jpi.12264","volume":"59","author":"A Fern\u00e1ndez","year":"2015","unstructured":"Fern\u00e1ndez A, Ord\u00f3\u00f1ez R, Reiter RJ, Gonz\u00e1lez-Gallego J, Mauriz JL. Melatonin and endoplasmic reticulum stress: relation to autophagy and apoptosis. J Pineal Res. 2015;59:292\u2013307.","journal-title":"J Pineal Res"},{"key":"449_CR34","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature05859","volume":"447","author":"N Yagoda","year":"2007","unstructured":"Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, et\u00a0al. RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 2007;447:864\u20138.","journal-title":"Nature"},{"key":"449_CR35","first-page":"2826","volume":"22","author":"Y Sun","year":"2020","unstructured":"Sun Y, Deng R, Zhang C. Erastin induces apoptotic and ferroptotic cell death by inducing ROS accumulation by causing mitochondrial dysfunction in gastric cancer cell HGC-27. Mol Med Rep. 2020;22:2826\u201332.","journal-title":"Mol Med Rep"},{"key":"449_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154605","volume":"11","author":"H Huo","year":"2016","unstructured":"Huo H, Zhou Z, Qin J, Liu W, Wang B, Gu Y. Erastin disrupts mitochondrial permeability transition pore (mPTP) and induces apoptotic death of colorectal cancer cells. PLoS ONE. 2016;11: e0154605.","journal-title":"PLoS ONE"},{"key":"449_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrc.2017.53","volume":"17","author":"JMM Levy","year":"2017","unstructured":"Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer. 2017;17:528\u201342.","journal-title":"Nat Rev Cancer"},{"key":"449_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105279","volume":"163","author":"J Wu","year":"2021","unstructured":"Wu J, Bai Y, Wang Y, Ma J. Melatonin and regulation of autophagy: mechanisms and therapeutic implications. Pharmacol Res. 2021;163: 105279.","journal-title":"Pharmacol Res"},{"key":"449_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40139-017-0139-5","volume":"5","author":"R Kang","year":"2017","unstructured":"Kang R, Tang D. Autophagy and Ferroptosis - What\u2019s the Connection? Curr Pathobiol Rep. 2017;5:153\u20139.","journal-title":"Curr Pathobiol Rep"},{"key":"449_CR40","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","volume":"12","author":"W Hou","year":"2016","unstructured":"Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ 3rd, et\u00a0al. Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 2016;12:1425\u20138.","journal-title":"Autophagy"},{"key":"449_CR41","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1080\/15548627.2021.1872241","volume":"17","author":"J Li","year":"2021","unstructured":"Li J, Liu J, Xu Y, Wu R, Chen X, Song X, et\u00a0al. Tumor heterogeneity in autophagy-dependent ferroptosis. Autophagy. 2021;17:3361\u201374.","journal-title":"Autophagy"},{"key":"449_CR42","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/cdd.2014.150","volume":"22","author":"G Filomeni","year":"2015","unstructured":"Filomeni G, De Zio D, Cecconi F. Oxidative stress and autophagy: the clash between damage and metabolic needs. Cell Death Differ. 2015;22:377\u201388.","journal-title":"Cell Death Differ"},{"key":"449_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s11658-022-00383-z","volume":"27","author":"Y Li","year":"2022","unstructured":"Li Y, Xu B, Ren X, Wang L, Xu Y, Zhao Y, et\u00a0al. Inhibition of CISD2 promotes ferroptosis through ferritinophagy-mediated ferritin turnover and regulation of p62-Keap1-NRF2 pathway. Cell Mol Biol Lett. 2022;27:81.","journal-title":"Cell Mol Biol Lett"},{"key":"449_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.envpol.2022.119449","volume":"307","author":"K Yin","year":"2022","unstructured":"Yin K, Wang D, Zhao H, Wang Y, Zhang Y, Liu Y, et\u00a0al. Polystyrene microplastics up-regulates liver glutamine and glutamate synthesis and promotes autophagy-dependent ferroptosis and apoptosis in the cerebellum through the liver-brain axis. Environ Pollut. 2022;307: 119449.","journal-title":"Environ Pollut"}],"container-title":["Cellular &amp; Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-023-00449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-023-00449-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-023-00449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T18:07:54Z","timestamp":1683050874000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-023-00449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["449"],"URL":"https:\/\/doi.org\/10.1186\/s11658-023-00449-6","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"20 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was approved by Committee on the Use of Live Animals in Teaching and Research (CULATR) of the university of Hong Kong (no. 5837-21, date: 18 August 2021).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}